Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Haematology|June 17, 2020
Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancyStephen Booth, John Willan, Henna Wong, et al.
Blood Advances|April 23, 2021
Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOPToby A Eyre, William Wilson, Amy A Kirkwood, et al.
Blood|October 28, 2020
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patientsAbi Vijenthira, Inna Y Gong, Thomas A Fox, et al.
Research and Practice in Thrombosis and Haemostasis|April 27, 2022
Risk of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination prior to the recognition of vaccine-induced thrombocytopenia and thrombosis: A self-controlled case series study in EnglandHannah Higgins, Nick Andrews, Julia Stowe, et al.
JAMA Network Open|February 21, 2022
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19Csilla Várnai, Claire Palles, Roland Arnold, et al.
Blood Advances|September 11, 2020
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphomaStephen Booth, Hannah Plaschkes, Amy A Kirkwood, et al.
British Journal of Haematology|August 9, 2022
Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative GroupSara Steffanoni, Teresa Calimeri, Alice Laurenge, et al.
British Journal of Haematology|November 11, 2021
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapyStephen Booth, Helen M Curley, Csilla Varnai, et al.
The Lancet. Oncology|August 28, 2020
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort studyLennard Y W Lee, Jean-Baptiste Cazier, Thomas Starkey, et al.
The Lancet. Oncology|December 14, 2024
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational studyAnna Santarsieri, Emily Mitchell, My H Pham, et al.
Pageof 3